Evidence map›Paper›PMID 39809975›Full record

ArticleNature metabolism2025

Multiplex genome editing eliminates lactate production without impacting growth rate in mammalian cells.

Hooman Hefzi, Iván Martínez-Monge, Igor Marin de Mas, Nicholas Luke Cowie, Alejandro Gomez Toledo, Soo Min Noh, Karen Julie la Cour Karottki, Marianne Decker, Johnny Arnsdorf, Jose Manuel Camacho-Zaragoza and 25 more

Abstract read
In one paragraph

Article in Nature metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Lactate Signal: Modulator of Cellular Energy Production and Anabolism.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

35 authors.

Hooman HefziDepartment of Bioengineering, University of California, University of California, San Diego, La Jolla, CA, USA. hoohef@dtu.dk.ORCID http://orcid.org/0009-0003-4067-6224
Iván Martínez-MongeNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Igor Marin de MasNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Nicholas Luke CowieNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.ORCID http://orcid.org/0000-0003-3367-2105
Alejandro Gomez ToledoDivision of Infection Medicine, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden.ORCID http://orcid.org/0000-0002-2103-7158
Soo Min NohDepartment of Biological Sciences, KAIST, Daejeon, Republic of Korea.
Karen Julie la Cour KarottkiNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.ORCID http://orcid.org/0000-0001-5631-6694
Marianne DeckerNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Johnny ArnsdorfNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Jose Manuel Camacho-ZaragozaNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Stefan KolNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Sanne SchoffelenNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Nuša PristovšekNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Anders Holmgaard HansenNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.ORCID http://orcid.org/0000-0002-6007-4787
Antonio A MiguezNational Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
Sara Petersen BjørnNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Karen Kathrine BrøndumNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Elham Maria JavidiNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Kristian Lund JensenNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Laura StanglInstitute of Pharmacology, Center of Physiology and Pharmacology and Comprehensive Cancer Center (CCC), Medical University of Vienna, Vienna, Austria.
Emanuel KreidlInstitute of Pharmacology, Center of Physiology and Pharmacology and Comprehensive Cancer Center (CCC), Medical University of Vienna, Vienna, Austria.
Thomas Beuchert KallehaugeNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Daniel LeyDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.
Patrice MénardNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Helle Munck PetersenNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Zulfiya SukhovaNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Anton BauerInstitute of Pharmacology, Center of Physiology and Pharmacology and Comprehensive Cancer Center (CCC), Medical University of Vienna, Vienna, Austria.
Emilio CasanovaInstitute of Pharmacology, Center of Physiology and Pharmacology and Comprehensive Cancer Center (CCC), Medical University of Vienna, Vienna, Austria.
Niall BarronNational Institute for Bioprocessing Research and Training (NIBRT), Blackrock, Dublin, Ireland.
Johan MalmströmDivision of Infection Medicine, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden.
Lars K NielsenNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.ORCID http://orcid.org/0000-0001-8191-3511
Gyun Min LeeNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.ORCID http://orcid.org/0000-0002-9876-7378
Helene Faustrup KildegaardNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Bjørn G VoldborgNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Nathan E LewisDepartment of Bioengineering, University of California, University of California, San Diego, La Jolla, CA, USA. nlewisres@ucsd.edu.ORCID http://orcid.org/0000-0001-7700-3654

Funding

Unraveling the mammalian secretory pathway through systems biology and algorithm developmentR35GM119850 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LEWIS, NATHAN ENOCH · 2016 to 2025
$4.3M
Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) 10.55776/P32900Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) 10.55776/P33430Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) 10.55776/P36728NIGMS NIH HHS R35 GM119850Novo Nordisk Fonden (Novo Nordisk Foundation) NNF10CC1016517Novo Nordisk Fonden (Novo Nordisk Foundation) NNF16CC0021858Novo Nordisk Fonden (Novo Nordisk Foundation) NNF20CC0035580Novo Nordisk Fonden (Novo Nordisk Foundation) NNF20SA0066621
6 · The paper itself

Abstract

The Warburg effect, which describes the fermentation of glucose to lactate even in the presence of oxygen, is ubiquitous in proliferative mammalian cells, including cancer cells, but poses challenges for biopharmaceutical production as lactate accumulation inhibits cell growth and protein production. Previous efforts to eliminate lactate production in cells for bioprocessing have failed as lactate dehydrogenase is essential for cell growth. Here, we effectively eliminate lactate production in Chinese hamster ovary and in the human embryonic kidney cell line HEK293 by simultaneous knockout of lactate dehydrogenases and pyruvate dehydrogenase kinases, thereby removing a negative feedback loop that typically inhibits pyruvate conversion to acetyl-CoA. These cells, which we refer to as Warburg-null cells, maintain wild-type growth rates while producing negligible lactate, show a compensatory increase in oxygen consumption, near total reliance on oxidative metabolism, and higher cell densities in fed-batch cell culture. Warburg-null cells remain amenable for production of diverse biotherapeutic proteins, reaching industrially relevant titres and maintaining product glycosylation. The ability to eliminate lactate production may be useful for biotherapeutic production and provides a tool for investigating a common metabolic phenomenon.

Indexed as

Cell ProliferationGene EditingLactic AcidAcetyl Coenzyme AAnimalsCell LineCricetinaeHumansLactate DehydrogenasesOxidation-ReductionPyruvate Dehydrogenase Acetyl-Transferring KinasePyruvic AcidAcetyl Coenzyme ALactate DehydrogenasesLactic AcidPyruvate Dehydrogenase Acetyl-Transferring KinasePyruvic Acid

Identifiers

PMID39809975
PMCPMC12272911

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.